Researchers Submit Patent Application, "Methods For Determining Sars-Cov-2 Antigen And Anti-Sars-Cov-2 Antibody In A Sample", for Approval (USPTO 20240069037).

A patent application has been submitted for a method of detecting the presence and quantity of SARS-CoV-2 antigens and anti-SARS-CoV-2 antibodies in a biological sample. The method utilizes microparticle reagents that bind specifically to the antigens and antibodies, along with detectable labels that indicate their presence. The biological sample can be obtained from sources like blood, saliva, or nasal mucus. This method has potential applications in assessing the transmission of the coronavirus and evaluating the immune response to SARS-CoV-2. The patent application provides comprehensive claims and additional information for further study. [Extracted from the article]